Topical application of oxifulvic acid suppresses the cutaneous immune response in mice
- 1 May 2001
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 53 (1) , 29-32
Abstract
The antiinflammatory activity of topically applied coal‐derived fulvic acids (called oxifulvic acid) at 4.5% and 9% was compared with that of diclofene sodium at 1% and betamethasone at 0.1% in a murine model of contact hypersensitivity. Mice were sensitised with dinitrofluorobenzene and challenged 6 days later by application to the dorsal surface of the right ear. The inflamed ears of the mice were then treated topically, and the thickness of the ears was measured daily. Oxifulvic acid at both concentrations compared favourably with both diclofene sodium and betamethasone in suppressing the cutaneous inflammatory response. Oxifulvic acid possesses antiinflammatory properties and may be of clinical benefit in the treatment of inflammatory skin conditions in humans. Drug Dev. Res. 53:29–32, 2001.Keywords
This publication has 4 references indexed in Scilit:
- An in vitro investigation of the antimicrobial activity of oxifulvic acidJournal of Antimicrobial Chemotherapy, 2000
- Adenovirus‐mediated blockade of lymphotoxin‐β inhibits the induction of contact sensitivity in miceExperimental Dermatology, 1997
- Non-catalytic oxidation of water-slurried coal with oxygen: identification of fulvic acids and acute toxicityFuel, 1997
- Free radicals in inflammation: second messengers and mediators of tissue destructionBritish Medical Bulletin, 1993